RE: Targeting £100m Annual Revenues17 Apr 2024 21:35
Because, Stephen, they’ve been assured finance from private sources. If they are determined to keep it on AIM and publicly funded then hiring another director would be tantamount to an act of self harm.
It’s just wrong. All wrong. They were hoping for some kind of big surge from that presentation but let’s face it, it was dreadful. A pathetic finale from Cheek saying the company is in a brilliant position was just a classic example of AIM Director desperation. I’ve heard similar recently from the likes of EISB announcing administration three weeks after a presentation in which the CEO talks about hopes for 2024 and heading for a profitable year of sales etc. it’s all bs and GDR are in the worst possible position financially.
I fluctuate between mildly optimistic and desperately pessimistic. One can’t be being realistic if after that presentation you think everything is going to be ok. It’s on a knife edge and given GDR’s track record with sales and the pedestrian rate of progress within the medical approval bodies, one just can’t be confident. You’re blind if you think or say it’s a great investment.